Robbins Umeda LLP Is Investigating Kendle International, Inc. Acquisition for Shareholders
May 05 2011 - 6:10PM
Business Wire
Robbins Umeda LLP, a shareholder rights litigation firm, is
interested in helping shareholders of Kendle International, Inc.
(NASDAQ: KNDL). The firm has commenced an investigation into
possible breaches of fiduciary duty and other violations of state
law by members of the board of directors of Kendle in connection
with their efforts to sell Kendle to INC Research, LLC, a
therapeutically focused global contract research organization.
If you own stock in Kendle and would like more information about
your shareholder rights, please contact Gregory E. Del Gaizo at
800-350-6003 or via the shareholder information form on our
website.
On May 4, 2011, INC and Kendle announced they have entered a
definitive merger agreement under which INC will acquire all the
outstanding shares of Kendle for $15.25 per share. The transaction
is expected to be consummated in the third quarter of 2011.
The investigation focuses on whether Kendle's board is
undertaking a fair process to obtain maximum value for its
shareholders. Of note, at least two analysts have price targets
higher than the offer price, one being as high as $17.00.
Robbins Umeda LLP represents individual and institutional
shareholders in derivative, direct, and class action lawsuits. The
firm's skilled litigation teams include former federal prosecutors,
former defense counsel from top multinational corporate law firms,
and career shareholder rights attorneys. Robbins Umeda LLP has
helped its clients realize more than $1 billion of value for
themselves and the companies in which they have invested. For more
information, please go to http://www.robbinsumeda.com.
Press release link:
http://www.robbinsumeda.com/shareholders-rights-blog/kendle-international-inc/
Attorney Advertising. Past results do not guarantee a similar
outcome.
Kendle (NASDAQ:KNDL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kendle (NASDAQ:KNDL)
Historical Stock Chart
From Jul 2023 to Jul 2024